Search

Author/Creator Lynch, Casey

2. P4‐663: INITIATION OF THE PHASE 2/3 GAIN TRIAL OF COR388, A NOVEL BACTERIAL VIRULENCE FACTOR INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE (AD) BASED ON PHASE I A/B SAFETY, PK, BIOMARKER AND EFFICACY DATA. (1st July 2019)

Authors:
Detke, Mike; Lynch, Casey; Holsinger, Leslie; Kapur, Shirin; Hennings, Dave; Raha, Debasish; Ermini, Florian; Haditsch, Ursula; Ryder, Mark; Goodman, Ira J.; Thein, Stephen G.; Dominy, Steve
Journal:
Alzheimer's & dementia
Issue:
Volume 15:Supplement 7(2019)Part 30
Page Start:
P1585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine‐gingipain inhibitor COR388. Issue 1 (30th January 2020)

Authors:
Arastu‐Kapur, Shirin; Nguyen, Mai; Raha, Debasish; Ermini, Florian; Haditsch, Ursula; Araujo, Joseph; De Lannoy, Ines A. M.; Ryder, Mark I.; Dominy, Stephen S.; Lynch, Casey; Holsinger, Leslie J.
Journal:
Pharmacology research & perspectives
Issue:
Volume 8:Issue 1(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗